<p>The current market price or CMP refers to the price of those companies associated with Krishna Yeachuri at which the securities are trading in the share market.</p>
<br>
<h2>Current price in Over-the-counter costs:</h2>
<p>The following current price of those
companies associated with Krishna Yeachuri depends
upon the bid price & the asking price when a financial asset is sold
over-the-counter(OTC).</p>
<br>
<h2>Current Price in Bond Market: </h2>
<p>The current price of a bond of those
companies associated with Krishna Yeachuri is determined by measuring
the actual interest rate against the bid-related interest rate.</p>
<br>
<p>The par or the face value is then calculated to
represent the remaining interest payments due which occur before the maturity
of the bond.</p>
Historical Share prices
* All values are in Rupees
Krishna Yeachuri Sector Specific Experience
About Krishna Yeachuri's work experience
Prior to becoming Non Executive Director, Krishna Yeachuri was Independent Director of Bafna Pharmaceuticals Ltd for 1 year in 2023.
Before becoming Independent Director, Krishna Yeachuri was Additional Director of Megasoft Ltd for 1 year in 2022.
Prior to becoming Additional Director, Krishna Yeachuri was Addtnl Non-Exe Dir &Indpnt Dir of Bafna Pharmaceuticals Ltd for 1 year in 2022.
FAQ's related Krishna Yeachuri
Which companies does Krishna Yeachuri serve as a board member for?
Krishna Yeachuri serves as a board member for: Megasoft Ltd,Bafna Pharmaceuticals Ltd
What positions has Krishna Yeachuri held in his/her career?
Throughout their career, Krishna Yeachuri has held key positions such as Non Executive Director,Independent Director,Additional Director,Addtnl Non-Exe Dir &Indpnt Dir, contributing to the growth and success of each company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.